In Alzheimer’s, Bristol Myers sees big promise beyond amyloid

BioPharma Dive

Bristol Myers' neuroscience heads are trying to make a name in brain drugs for a company best known for its cancer and cell therapy work.

pharminent May 21, 2026 (Last updated: May 21, 2026)

BioPharma Dive

Bristol Myers’ neuroscience heads are trying to make a name in brain drugs for a company best known for its cancer and cell therapy work.

Related Stories